BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29552200)

  • 1. CD44 promotes cell proliferation in non-small cell lung cancer.
    Hu B; Ma Y; Yang Y; Zhang L; Han H; Chen J
    Oncol Lett; 2018 Apr; 15(4):5627-5633. PubMed ID: 29552200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2.
    Zhang G; Zheng H; Zhang G; Cheng R; Lu C; Guo Y; Zhao G
    Cancer Cell Int; 2017; 17():46. PubMed ID: 28428733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Jiang J; Ren H; Xu Y; Wudu M; Wang Q; Liu Z; Su H; Jiang X; Zhang Y; Zhang B; Qiu X
    J Cancer; 2020; 11(5):1240-1249. PubMed ID: 31956370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldolase A promotes proliferation and G
    Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
    Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA RPPH1 promotes non-small cell lung cancer progression through the miR-326/WNT2B axis.
    Wu Y; Cheng K; Liang W; Wang X
    Oncol Lett; 2020 Oct; 20(4):105. PubMed ID: 32831924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
    Cui D; Yu CH; Liu M; Xia QQ; Zhang YF; Jiang WL
    Tumour Biol; 2016 Mar; 37(3):4127-34. PubMed ID: 26490983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic activation of SIN1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
    Hu Z; Wang Y; Wang Y; Zang B; Hui H; You Z; Wang X
    Biochem Biophys Res Commun; 2017 Jan; 483(1):645-651. PubMed ID: 27993679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circular RNA CircHIPK3 Promotes NCI-H1299 and NCI-H2170 Cell Proliferation through miR-379 and its Target IGF1].
    Tian F; Wang Y; Xiao Z; Zhu X
    Zhongguo Fei Ai Za Zhi; 2017 Jul; 20(7):459-467. PubMed ID: 28738961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal miR-660-5p promotes tumor growth and metastasis in non-small cell lung cancer.
    Qi Y; Zha W; Zhang W
    J BUON; 2019; 24(2):599-607. PubMed ID: 31128012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
    Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
    J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
    Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC.
    Wang R; Dong HX; Zeng J; Pan J; Jin XY
    J Cell Physiol; 2018 Sep; 233(9):7447-7456. PubMed ID: 29663359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-7-5p induces cell growth inhibition, cell cycle arrest and apoptosis by targeting PAK2 in non-small cell lung cancer.
    Li Q; Wu X; Guo L; Shi J; Li J
    FEBS Open Bio; 2019 Nov; 9(11):1983-1993. PubMed ID: 31587474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway.
    Sun QS; Luo M; Zhao HM; Sun H
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4210-4219. PubMed ID: 31173292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
    Jing H; Xia H; Qian M; Lv X
    Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
    Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
    J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARK2 Suppresses Proliferation and Tumorigenicity in Non-small Cell Lung Cancer.
    Duan H; Lei Z; Xu F; Pan T; Lu D; Ding P; Zhu C; Pan C; Zhang S
    Front Oncol; 2019; 9():790. PubMed ID: 31508359
    [No Abstract]   [Full Text] [Related]  

  • 20. EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells.
    Jiang P; Xu C; Chen L; Chen A; Wu X; Zhou M; Haq IU; Mariyam Z; Feng Q
    Mol Carcinog; 2018 Dec; 57(12):1835-1844. PubMed ID: 30182373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.